Environmental conditions and their impact on host immunity
环境条件及其对宿主免疫力的影响
基本信息
- 批准号:8588929
- 负责人:
- 金额:$ 7.51万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-12-01 至 2014-11-30
- 项目状态:已结题
- 来源:
- 关键词:AdjuvantAllergicAllergic DiseaseAllergic ReactionAluminumAnaphylaxisAntibioticsAntigensAreaAsthmaBacterial InfectionsBasophilsCD4 Positive T LymphocytesCessation of lifeChildDeveloped CountriesDeveloping CountriesDevelopmentDiseaseEczemaElementsEndotoxinsEnvironmentEnvironmental Risk FactorEpidemiologyEquilibriumExposure toFarming environmentFood HypersensitivityFoundationsFutureGoalsHay feverHelper-Inducer T-LymphocyteHospitalizationHouse miceHumanHygieneHypersensitivityIgEImmuneImmune systemImmunityImmunizationIncidenceInfectionInterferonsInterleukin-12Interleukin-4LifeMeasuresMediatingModelingMonitorMusPeanuts - dietaryPhenotypePredispositionPrevalencePreventionProductionReactionResearchRiskRisk FactorsSeveritiesSignal TransductionSodium ChlorideUnited StatesVaccinatedVaccinationVaccine AdjuvantVaccinesVirus Diseasescytokinedesignenvironmental allergyexperienceimprovedmast cellmouse modelnovelpreventpublic health relevanceresearch studyresponsetoll-like receptor 4
项目摘要
DESCRIPTION (provided by applicant): Industrialized countries have experienced an increase in Th2-dependent, IgE- mediated allergic diseases such as food allergy, asthma, and hay fever. Food allergy causes 30,000 cases of anaphylaxis and 200 deaths annually in the United States alone. The cause for the escalation in allergic disease remains unknown. In recent decades, potential risk factors such as improved living conditions and the use of aluminum (alum)-adjuvanted vaccines have been proposed as being associated with the increased prevalence of allergic disease. It is our hypothesis that the cumulative effect of the allergy risk factors creates a Th2-biased immune environment in the host that predisposes the host to the development of allergy. The goal of this proposal is to utilize a mouse model to determine if the presence of proposed allergy risk factors including low LPS environment and exposure to alum-adjuvanted vaccines influences the phenotype of the host systemic and mucosal immune system. Additionally, we will determine if the presence of these allergy risk factors influences the development of allergic sensitization to peanut. To achieve this goal, mice will be maintained in standard mouse housing conditions or in conditions designed to mimic modern, industrialized countries that have experienced increased allergic diseases. The "modern" conditions will include low endotoxin, exposure to alum-adjuvanted immunizations or low endotoxin combined with alum-adjuvanted vaccines. All mice will be sensitized to peanut antigens. Upon completion of sensitization mice will be challenged with peanut and monitored for the incidence and severity of an allergic reaction. The experiments proposed in this application will provide the foundation for future mechanistic studies to define environmental factors that contribute to the increased prevalence of food allergy and provide a model to evaluate novel therapies for their ability to prevent the induction of peanut food allergy.
描述(由申请人提供):工业化国家经历了th2依赖性、IgE介导的过敏性疾病的增加,如食物过敏、哮喘和花粉热。仅在美国,食物过敏每年就会导致3万例过敏反应和200例死亡。过敏性疾病增加的原因尚不清楚。近几十年来,生活条件的改善和铝(明矾)佐剂疫苗的使用等潜在风险因素被认为与过敏性疾病的患病率增加有关。我们的假设是,过敏风险因素的累积效应在宿主体内创造了一个th2偏倚的免疫环境,使宿主容易发生过敏。本研究的目的是利用小鼠模型来确定包括低脂多糖环境和暴露于铝佐剂疫苗在内的过敏风险因素是否会影响宿主全身和粘膜免疫系统的表型。此外,我们将确定这些过敏风险因素的存在是否会影响花生过敏敏化的发展。为了实现这一目标,将把小鼠饲养在标准的小鼠住房条件下,或在模拟现代工业化国家的条件下饲养,这些国家的过敏性疾病正在增加。“现代”条件将包括低内毒素,暴露于铝佐剂免疫或低内毒素结合铝佐剂疫苗。所有的老鼠都会对花生抗原敏感。致敏试验完成后,将用花生刺激小鼠,并监测过敏反应的发生率和严重程度。本应用程序中提出的实验将为未来的机制研究提供基础,以确定导致食物过敏患病率增加的环境因素,并为评估新疗法预防诱导花生食物过敏的能力提供模型。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Herman F Staats其他文献
Herman F Staats的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Herman F Staats', 18)}}的其他基金
Developing RNA Vaccines to Treat Peanut Hypersensitivity
开发治疗花生过敏的 RNA 疫苗
- 批准号:
10570339 - 财政年份:2023
- 资助金额:
$ 7.51万 - 项目类别:
Mucosal vaccination to protect against HIV-1 infection at mucosal sites
粘膜疫苗接种可预防粘膜部位的 HIV-1 感染
- 批准号:
8410154 - 财政年份:2012
- 资助金额:
$ 7.51万 - 项目类别:
Mucosal vaccination to protect against HIV-1 infection at mucosal sites
粘膜疫苗接种可预防粘膜部位的 HIV-1 感染
- 批准号:
8685120 - 财政年份:2012
- 资助金额:
$ 7.51万 - 项目类别:
Evaluation of the nasal adjuvant activity of angiotensin peptide Ang-(1-7)
血管紧张素肽Ang-(1-7)的鼻佐剂活性评价
- 批准号:
8431730 - 财政年份:2012
- 资助金额:
$ 7.51万 - 项目类别:
Evaluation of the nasal adjuvant activity of angiotensin peptide Ang-(1-7)
血管紧张素肽Ang-(1-7)的鼻佐剂活性评价
- 批准号:
8245668 - 财政年份:2012
- 资助金额:
$ 7.51万 - 项目类别:
Mucosal vaccination to protect against HIV-1 infection at mucosal sites
粘膜疫苗接种可预防粘膜部位的 HIV-1 感染
- 批准号:
8500195 - 财政年份:2012
- 资助金额:
$ 7.51万 - 项目类别:
Environmental conditions and their impact on host immunity
环境条件及其对宿主免疫力的影响
- 批准号:
8431837 - 财政年份:2012
- 资助金额:
$ 7.51万 - 项目类别:
EVALUATION OF A PRIME-BOOST VACCINE FOR AEROSOL RICIN EXPOSURE IN NHPS
评估 NHPS 中气溶胶蓖麻毒素暴露的初免加强疫苗
- 批准号:
8358152 - 财政年份:2011
- 资助金额:
$ 7.51万 - 项目类别:
Nasal Vaccines: Mode of Action, Composition & Delivery
鼻腔疫苗:作用方式、成分
- 批准号:
8069023 - 财政年份:2010
- 资助金额:
$ 7.51万 - 项目类别:
Development of Efficacious and Stable Nasal Vaccine Formulations
有效且稳定的鼻疫苗制剂的开发
- 批准号:
7802325 - 财政年份:2009
- 资助金额:
$ 7.51万 - 项目类别:
相似海外基金
Elucidating the Role of Cutaneous Environmental Factors in the Development of Allergic Disease
阐明皮肤环境因素在过敏性疾病发展中的作用
- 批准号:
10664255 - 财政年份:2023
- 资助金额:
$ 7.51万 - 项目类别:
Regulatory mechanism of allergic disease development by inhibitory co-receptors
抑制性共受体对过敏性疾病发生的调控机制
- 批准号:
22H02888 - 财政年份:2022
- 资助金额:
$ 7.51万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Control of ST2+ Treg Development in Allergic Disease by Bcl6 and Sex Hormone Receptors
Bcl6 和性激素受体控制过敏性疾病中 ST2 Treg 的发育
- 批准号:
10633229 - 财政年份:2022
- 资助金额:
$ 7.51万 - 项目类别:
Deep Phenotyping of Allergic Disease and Environmental Allergen Component Sensitization
过敏性疾病的深层表型分析和环境过敏原成分致敏
- 批准号:
22K10545 - 财政年份:2022
- 资助金额:
$ 7.51万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigation of the prevalence, presentation and immunologic features of the α-Gal syndrome in a high-risk cohort not recruited on the basis of allergic disease
未根据过敏性疾病招募的高危人群中 α-Gal 综合征的患病率、表现和免疫学特征的调查
- 批准号:
10670058 - 财政年份:2022
- 资助金额:
$ 7.51万 - 项目类别:
Elucidation of immune and allergic disease dynamics by integrative sequencing analysis
通过整合测序分析阐明免疫和过敏性疾病动态
- 批准号:
22H00476 - 财政年份:2022
- 资助金额:
$ 7.51万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Investigation of the prevalence, presentation and immunologic features of the α-Gal syndrome in a high-risk cohort not recruited on the basis of allergic disease
未根据过敏性疾病招募的高危人群中 α-Gal 综合征的患病率、表现和免疫学特征的调查
- 批准号:
10353468 - 财政年份:2022
- 资助金额:
$ 7.51万 - 项目类别:
Control of ST2+ Treg Development in Allergic Disease by Bcl6 and Sex Hormone Receptors
Bcl6 和性激素受体控制过敏性疾病中 ST2 Treg 的发育
- 批准号:
10535286 - 财政年份:2022
- 资助金额:
$ 7.51万 - 项目类别:
Humoral Immunoregulation of Allergic Disease by Follicular T Cell Subsets
滤泡 T 细胞亚群对过敏性疾病的体液免疫调节
- 批准号:
10570227 - 财政年份:2021
- 资助金额:
$ 7.51万 - 项目类别:
Investigating the effect of maternal microbiome on fetal hematopoiesis and subsequent susceptibility to allergic disease
研究母体微生物组对胎儿造血和随后对过敏性疾病的易感性的影响
- 批准号:
467169 - 财政年份:2021
- 资助金额:
$ 7.51万 - 项目类别:
Studentship Programs














{{item.name}}会员




